Simulations Plus has announced a collaboration with Nvidia aimed at speeding up drug development by combining advanced simulation software with GPU-powered computing and artificial intelligence tools.

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and ...

Simulations Plus, Inc. SLP shares are trading lower on Wednesday as the company announced a collaboration with NVIDIA Corp ...

Simulations Plus is a global leader in model-informed and AI-accelerated drug development. We create value for our clients by accelerating the discovery, development, and commercialization of ...

Recent advances in AI, quantum computing, and physics-based modeling are dramatically accelerating and expanding the scope of simulations across domains from spaceflight to drug discovery.

Orion Corporation and Aitia, an AI-enabled biotechnology company and the leader in the development and application of Causal AI and "Digital Twins" to discover and develop new drugs, announced today ...